Cargando…

Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis

BACKGROUND AND AIM: Data on quantitative metabolic liver functions in the life-threatening disease alcoholic hepatitis are scarce. Urea synthesis is an essential metabolic liver function that plays a key regulatory role in nitrogen homeostasis. The urea synthesis capacity decreases in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glavind, Emilie, Aagaard, Niels Kristian, Grønbæk, Henning, Møller, Holger Jon, Orntoft, Nikolaj Worm, Vilstrup, Hendrik, Thomsen, Karen Louise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933397/ https://www.ncbi.nlm.nih.gov/pubmed/27379798 http://dx.doi.org/10.1371/journal.pone.0158388

Ejemplares similares

Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
por: Ørntoft, Nikolaj Worm, et al.
Publicado: (2021)

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis
por: Svart, Mads, et al.
Publicado: (2018)

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
por: Rittig, Nikolaj, et al.
Publicado: (2017)

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
por: Björklund, Jessica, et al.
Publicado: (2018)

β-Blockers Improve Presinusoidal Portal Hypertension
por: Sørensen, Michael, et al.
Publicado: (2018)

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
por: Glavind, Emilie, et al.
Publicado: (2020)

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial
por: Naimi, Rahim Mohammad, et al.
Publicado: (2019)

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2017)

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease
por: Christensen, Claus Uhrenholt, et al.
Publicado: (2018)

Portal vein thrombosis; risk factors, clinical presentation and treatment
por: Sogaard, Kirstine K, et al.
Publicado: (2007)

Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention
por: Carstens, Jan, et al.
Publicado: (2007)

Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes
por: Svendsen, Pia, et al.
Publicado: (2016)

Correction: Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved
por: Eriksen, Peter Lykke, et al.
Publicado: (2023)

Isolated congenital hepatic fibrosis associated with TMEM67 mutations: report of a new genotype–phenotype relationship
por: Vogel, Ida, et al.
Publicado: (2017)

Experimental non-alcoholic fatty liver disease causes regional liver functional deficits as measured by the capacity for galactose metabolism while whole liver function is preserved
por: Eriksen, Peter Lykke, et al.
Publicado: (2022)

Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux‐en‐Y gastric bypass
por: Kazankov, Konstantin, et al.
Publicado: (2022)

No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation
por: Støy, Sidsel, et al.
Publicado: (2021)

Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study
por: Grønbæk, Henning, et al.
Publicado: (2008)

Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study
por: Jepsen, Peter, et al.
Publicado: (2009)

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis
por: Haldrup, David, et al.
Publicado: (2018)

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
por: Støy, Sidsel, et al.
Publicado: (2013)

Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020)

Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort study
por: Jepsen, Peter, et al.
Publicado: (2012)

Correction: Decreased monocyte shedding of the migration inhibitor soluble CD18 in alcoholic hepatitis
por: Støy, Sidsel, et al.
Publicado: (2018)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

A New Serum Macrophage Checkpoint Biomarker for Innate Immunotherapy: Soluble Signal-Regulatory Protein Alpha (sSIRPα)
por: Vladimirova, Yoanna V., et al.
Publicado: (2022)

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
por: Kazankov, Konstantin, et al.
Publicado: (2020)

Impaired hepatic counterregulatory response to insulin-induced hypoglycemia in hepatic denervated pigs
por: Nielsen, Michael Festersen, et al.
Publicado: (2015)

Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Preparation, Characterization, Solubility, and Antioxidant Capacity of Ellagic Acid-Urea Complex
por: Sakurai, Hitomi, et al.
Publicado: (2022)

Role of ammonia in NAFLD: An unusual suspect
por: Thomsen, Karen Louise, et al.
Publicado: (2023)

Reply to: “Hepatic bile acid transport increases in the postprandial state: A functional (11)C-CSar PET/CT study in healthy humans”
por: Ørntoft, Nikolaj W., et al.
Publicado: (2021)

Investigating effects of sodium beta‐hydroxybutyrate on metabolism in placebo‐controlled, bilaterally infused human leg with focus on skeletal muscle protein dynamics
por: Thomsen, Henrik Holm, et al.
Publicado: (2022)

Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide
por: Nielsen, Susanne Schouw, et al.
Publicado: (2006)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

Phosphatases Decrease Water and Urea Permeability in Rat Inner Medullary Collecting Ducts
por: Wang, Yanhua, et al.
Publicado: (2023)

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?
por: Kornerup, Linda Skibsted, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_phaforc3b8r2bo78mlmfd7nltj